Co-Codamol (Panadeine CO)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 35.6%
Rheumatoid Arthritis 16.9%
Symphysiolysis 6.8%
Back Pain 5.1%
Pregnancy 5.1%
Migraine 3.4%
Pain 3.4%
Vitamin B12 Deficiency 3.4%
Analgesia 1.7%
Blood Cholesterol Increased 1.7%
Depressed Mood 1.7%
Diabetes Mellitus 1.7%
Erectile Dysfunction 1.7%
Fall 1.7%
Fungal Infection 1.7%
Gastrointestinal Ulcer 1.7%
Immunisation 1.7%
Joint Injury 1.7%
Musculoskeletal Pain 1.7%
Oropharyngeal Pain 1.7%
Suicidal Ideation 18.8%
Gastroenteritis Viral 12.5%
Abnormal Behaviour 6.3%
Blood Potassium Decreased 6.3%
Continuous Haemodiafiltration 6.3%
Drug Exposure During Pregnancy 6.3%
Headache 6.3%
Hip Dysplasia 6.3%
Maternal Exposure During Pregnancy 6.3%
Neonatal Infection 6.3%
Urinary Incontinence 6.3%
Urinary Tract Infection 6.3%
Weight Increased 6.3%
Concomitant
Product Used For Unknown Indication 28.1%
Osteoporosis 11.1%
Depression 9.6%
Drug Use For Unknown Indication 8.9%
Non-small Cell Lung Cancer 5.9%
Hypertension 4.4%
Pancreatic Carcinoma Metastatic 4.4%
Helicobacter Infection 3.7%
Hepatic Neoplasm Malignant 3.0%
Lower Respiratory Tract Infection 3.0%
Pilonidal Cyst 3.0%
Drug Use For Unknown Indication 2.2%
Prostate Cancer 2.2%
Benign Prostatic Hyperplasia 1.5%
Bipolar Disorder 1.5%
Candidiasis 1.5%
Insomnia 1.5%
Muscle Spasticity 1.5%
Osteoarthritis 1.5%
Osteoporosis Prophylaxis 1.5%
Sepsis 9.6%
Myalgia 7.7%
Renal Failure Acute 7.7%
Tremor 7.7%
Vertigo 7.7%
Arthralgia 5.8%
Asthenia 3.8%
Clostridium Test Positive 3.8%
Decreased Appetite 3.8%
Drug Eruption 3.8%
Erectile Dysfunction 3.8%
Haemoptysis 3.8%
Hypernatraemia 3.8%
Hypersensitivity 3.8%
Oesophageal Carcinoma 3.8%
Pain 3.8%
Pancreatitis 3.8%
Polyuria 3.8%
Pulmonary Embolism 3.8%
Pulmonary Oedema 3.8%

Drug Data